As of 2025-07-14, the Intrinsic Value of Revolution Medicines Inc (RVMD) is -16.11 USD. This RVMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 38.02 USD, the upside of Revolution Medicines Inc is -142.37%.
Based on its market price of 38.02 USD and our intrinsic valuation, Revolution Medicines Inc (RVMD) is overvalued by 142.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.11 - -16.11 | -16.11 | -142.37% |
| P/E | (57.47) - (77.83) | (70.07) | -284.3% |
| DDM - Stable | (20.96) - (71.00) | (45.98) | -220.9% |
| DDM - Multi | (14.13) - (39.27) | (21.03) | -155.3% |
| Market Cap (mil) | 7,081.99 |
| Beta | 1.01 |
| Outstanding shares (mil) | 186.27 |
| Enterprise Value (mil) | 6,748.43 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.42% |
| Cost of Debt | 5.00% |
| WACC | 8.21% |